The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy

Abstract

MSCs treatment may have a positive impact on the survival rates of sepsis during the early phase. However, further randomized controlled studies with a large group of patients are needed. <i>Trial Registration</i>. This trial is registered with ClinicalTrials.gov Identifier: NCT05283317.